{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:17Z","timestamp":1791461357265,"version":"4.3.4"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s43440-025-00737-2","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:21:21Z","timestamp":1750288881000},"page":"1196-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The application of telmisartan in central nervous system disorders"],"prefix":"10.1007","volume":"77","author":[{"given":"Wei","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-9744","authenticated-orcid":false,"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"2","key":"737_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1124\/pr.112.007278","volume":"65","author":"MC Michel","year":"2013","unstructured":"Michel MC, Foster C, Brunner HR, Liu L.A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev. 2013;65(2):809\u201348.","journal-title":"Pharmacol Rev"},{"key":"737_CR2","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1517\/14656566.2011.632367","volume":"12","author":"M Destro","year":"2011","unstructured":"Destro M, Cagnoni F, Dognini GP, Galimberti V, Taietti C, Cavalleri C, et al. Telmisartan: just an antihypertensive agent? A literature review. Expert Opin Pharmacother 2011;12:2719\u201335.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"737_CR3","first-page":"259","volume":"69","author":"N Hattori","year":"2022","unstructured":"Hattori N, Yamada A, Nakatsuji S, Matsuda T, Nishiyama N, Shimatsu A.Telmisartan is the most effective ARB to increase adiponectin via PPAR\u03b1 in adipocytes. J Mol Endocrinol. 2022;69(1):259\u201368.","journal-title":"J Mol Endocrinol"},{"issue":"7","key":"737_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17425255.2010.494597","volume":"6","author":"S Deppe","year":"2010","unstructured":"Deppe S, B\u00f6ger RH, Weiss J, Benndorf RA.Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties. Expert Opin Drug Metab Toxicol. 2010;6(7):863\u201371.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"737_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JAD-230133","volume":"94","author":"XX Fu","year":"2023","unstructured":"Fu XX, Wei B, Cao HM, Duan R, Deng Y, Lian HW, et al. Telmisartan Alleviates Alzheimer\u2019s Disease-Related Neuropathologies and Cognitive Impairments. J Alzheimers Dis 2023;94:919\u201333.","journal-title":"J Alzheimers Dis"},{"key":"737_CR6","first-page":"110761","volume-title":"Telmisartan Inhibits Microglia-induced Neurotoxic A1 Astrocyte Conversion via PPAR\u03b3-mediated NF-\u03baB\/p65 Degradation","author":"W Quan","year":"2023","unstructured":"Quan W, Xu CS, Li XC, Yang C, Lan T, Wang MY, et al. Telmisartan Inhibits Microglia-induced Neurotoxic A1 Astrocyte Conversion via PPAR\u03b3-mediated NF-\u03baB\/p65 Degradation. vol. 123, Int Immunopharmacol; 2023. 110761."},{"key":"737_CR7","first-page":"80","volume-title":"Intranasal Telmisartan Ameliorates Brain Pathology in Five Familial Alzheimer\u2019s Disease Mice","author":"N Torika","year":"2017","unstructured":"Torika N, Asraf K, Cohen H, Fleisher-Berkovich S. Intranasal Telmisartan Ameliorates Brain Pathology in Five Familial Alzheimer\u2019s Disease Mice. vol. 64. Brain Behav Immun; 2017. p. 80\u201390."},{"key":"737_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12975-022-01121-5","volume":"15","author":"X Guan","year":"2024","unstructured":"Guan X, Wu J, Geng J, Ji D, Wei D, Ling Y, et al. A Novel Hybrid of Telmisartan and Borneol Ameliorates Neuroinflammation and White Matter Injury in Ischemic Stroke Through ATF3\/CH25H Axis. Transl Stroke Res 2024;15:195\u2013218.","journal-title":"Transl Stroke Res"},{"issue":"4","key":"737_CR9","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1021\/acsabm.4c00246","volume":"7","author":"AF Madani","year":"2024","unstructured":"Madani AF, Syauqi MA, Permatasari JA, Putri AA, F. M, Permana AD.Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: a Potentially Promising Treatment for Alzheimer\u2019s with an Improved Pharmacokinetic Profile. ACS Appl Bio Mater. 2024;7(4):2582\u201393.","journal-title":"ACS Appl Bio Mater"},{"key":"737_CR10","first-page":"111254","volume-title":"Renin-angiotensin System and Inflammation Update","author":"E Cantero-Navarro","year":"2021","unstructured":"Cantero-Navarro E, Fern\u00e1ndez-Fern\u00e1ndez B, Ramos AM, Rayego-Mateos S, Rodrigues-Diez RR, S\u00e1nchez-Ni\u00f1o MD, et al. Renin-angiotensin System and Inflammation Update. vol. 529, Mol Cell Endocrinol; 2021. 111254."},{"key":"737_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.coph.2015.01.006","volume":"21","author":"D Chen","year":"2015","unstructured":"Chen D, Coffman TM. AT1 Angiotensin receptors-vascular and renal epithelial pathways for blood pressure regulation. Curr Opin Pharmacol. 2015;21:122\u201326.","journal-title":"Curr Opin Pharmacol"},{"key":"737_CR12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, et al. Angiotensin II Signal Transduction: an Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev 2018;98:1627\u2013738.","journal-title":"Physiol Rev"},{"key":"737_CR13","first-page":"3627","volume-title":"Anti-Diabetic Effect of Telmisartan through Its Partial PPAR\u03b3-Agonistic Activity","author":"MA Ayza","year":"2020","unstructured":"Ayza MA, Zewdie KA, Tesfaye BA, Gebrekirstos ST, Berhe DF. Anti-Diabetic Effect of Telmisartan through Its Partial PPAR\u03b3-Agonistic Activity. vol. 13. Diabetes Metab Syndr Obes; 2020. p. 3627\u201335."},{"key":"737_CR14","doi-asserted-by":"publisher","first-page":"105639","DOI":"10.1016\/j.phrs.2021.105639","volume":"169","author":"S Zheng","year":"2021","unstructured":"Zheng S, Huang H, Li Y, Wang Y, Zheng Y, Liang J, et al. Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPAR\u03b3-LXR\u03b1-ABCA1\/ABCG1 pathway. Pharmacol Res. 2021;169:105639.","journal-title":"Pharmacol Res"},{"issue":"12","key":"737_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B.PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"737_CR16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","volume":"483","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Yadav A, Chaturvedi RK.Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. Biochem Biophys Res Commun. 2017;483(4):1166\u201377.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"737_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/bab.2123","volume":"69","author":"AR Devan","year":"2022","unstructured":"Devan AR, Nair B, Kumar AR, Nath LR.An insight into the role of telmisartan as PPAR-\u03b3\/\u03b1 dual activator in the management of nonalcoholic fatty liver disease. Biotechnol Appl Biochem. 2022;69(2):461\u201368.","journal-title":"Biotechnol Appl Biochem"},{"issue":"9204","key":"737_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","volume":"355","author":"M Burnier","year":"2000","unstructured":"Burnier M, Brunner HR.Angiotensin II receptor antagonists. Lancet. 2000;355(9204):637\u201345.","journal-title":"Lancet"},{"key":"737_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejphar.2016.07.021","volume":"789","author":"FM Younis","year":"2016","unstructured":"Younis FM, Blumenthal-Katzir T, Hollander K, Grigoriadis N, Touloumi O, Lagoudakic R, et al. Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology. Eur J Pharmacol. 2016;789:88\u201397.","journal-title":"Eur J Pharmacol"},{"key":"737_CR20","doi-asserted-by":"crossref","unstructured":"Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, et al. Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med. 2009;151(1):1\u201310,w1\u20132.","DOI":"10.7326\/0003-4819-151-1-200907070-00122"},{"key":"737_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/jvim.16689","volume":"37","author":"V Fabr\u00e8s","year":"2023","unstructured":"Fabr\u00e8s V, Dumont R, Garcia M, Rosenberg D, Rannou B, Kurtz M, et al. Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats. J Vet Intern Med 2023;37:1341\u201347.","journal-title":"J Vet Intern Med"},{"key":"737_CR22","doi-asserted-by":"crossref","unstructured":"Wang GM, Li LJ, Fan L, Xu M, Tang WL, Wright JM. Renin inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2025;2:2. Cd012570","DOI":"10.1002\/14651858.CD012570.pub2"},{"issue":"1","key":"737_CR23","first-page":"28","volume":"62","author":"M Kuroki","year":"2024","unstructured":"Kuroki M, Suzuki H, Onodera Y, Nakane M, Kawamae K.Association Between Long- Versus Short-Acting Angiotensin II Receptor Antagonists and Hypotension During Anesthesia Induction: a Retrospective Study. Asian J Anesthesiol. 2024;62(1):28\u201338.","journal-title":"Asian J Anesthesiol"},{"key":"737_CR24","first-page":"205031212097350","volume-title":"Renal Outcomes of Treatment with Telmisartan in Patients with Stage 3\u20134 Chronic Kidney Disease: a Prospective, Randomized, Controlled Trial (JINNAGA)","author":"M Kitamura","year":"2020","unstructured":"Kitamura M, Arai H, Abe S, Ota Y, Muta K, Furusu A, et al. Renal Outcomes of Treatment with Telmisartan in Patients with Stage 3\u20134 Chronic Kidney Disease: a Prospective, Randomized, Controlled Trial (JINNAGA). vol. 8, SAGE Open Med; 2020. 2050312120973502."},{"issue":"8","key":"737_CR25","first-page":"e9858","volume":"12","author":"S Gaba","year":"2020","unstructured":"Gaba S, Jesrani G, Gupta S, Gupta M.Acute Kidney Injury and Hyperkalemia With Precarious Electrocardiographic Changes Caused by Concurrent Use of Telmisartan and Diclofenac. Cureus. 2020;12(8):e9858.","journal-title":"Cureus"},{"issue":"1","key":"737_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/21556660.2016.1252380","volume":"5","author":"A Agrawal","year":"2016","unstructured":"Agrawal A, Kamila S, Reddy S, Lilly J, Mariyala MS.Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational study. J Drug Assess. 2016;5(1):24\u201328.","journal-title":"J Drug Assess"},{"key":"737_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/2047487313510678","volume":"21","author":"HJ Heerspink","year":"2014","unstructured":"Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, et al. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Eur J Prev Cardiol 2014;21:299\u2013309.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"737_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/08037051.2010.488056","volume":"19","author":"M Cakir","year":"2010","unstructured":"Cakir M.Significant hyperkalemia and hyponatremia secondary to telmisartan\/hydrochlorothiazide treatment. Blood Press. 2010;19(6):380\u201382.","journal-title":"Blood Press"},{"key":"737_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1248\/bpb.b20-00174","volume":"43","author":"A Hosoda","year":"2020","unstructured":"Hosoda A, Matsumoto Y, Toriyama Y, Tsuji T, Yoshida Y, Masamichi S, et al. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model. Biol Pharm Bull 2020;43:1331\u201337.","journal-title":"Biol Pharm Bull"},{"key":"737_CR30","doi-asserted-by":"publisher","first-page":"C1366","DOI":"10.1152\/ajpcell.01036.2024","volume":"328","author":"X Zhang","year":"2025","unstructured":"Zhang X, Gaballa MMS, Hasan AA, Liu Y, Hocher JG, Chen X, et al. Effects of high salt intake on glucose metabolism, liver function, and the microbiome in rats: influence of ACE inhibitors and angiotensin II receptor blockers. Am J Physiol Cell Physiol 2025;328:C1366\u2013c1382.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"737_CR31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s11096-024-01755-5","volume":"46","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Yang H, Guo H.Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis. Int J Clin Pharm. 2024;46(5):1034\u201343.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"737_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pharmthera.2009.07.007","volume":"125","author":"AE Cuadra","year":"2010","unstructured":"Cuadra AE, Shan Z, Sumners C, Raizada MK.A current view of brain renin-angiotensin system: is the (pro)renin receptor the missing link? Pharmacol Ther. 2010;125(1):27\u201338.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"737_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-215231","volume":"85","author":"S Tran","year":"2022","unstructured":"Tran S, Kuruppu S, Rajapakse NW.Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: common Mechanisms Underlying Hypertension and Dementia? J Alzheimers Dis. 2022;85(3):943\u201355.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"737_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","volume":"13","author":"JL Labandeira-Garcia","year":"2024","unstructured":"Labandeira-Garcia JL, Labandeira CM, Guerra MJ, Rodriguez-Perez AI.The role of the brain renin-angiotensin system in Parkinson\u00b4s disease. Transl Neurodegener. 2024;13(1):22.","journal-title":"Transl Neurodegener"},{"key":"737_CR35","first-page":"650","volume-title":"Interactions of the Brain Renin-Angiotensin-System (RAS) and Inflammation in the Sensitization of Hypertension","author":"B Xue","year":"2020","unstructured":"Xue B, Zhang Y, Johnson AK. Interactions of the Brain Renin-Angiotensin-System (RAS) and Inflammation in the Sensitization of Hypertension. vol. 14. Front Neurosci; 2020. p. 650."},{"issue":"1","key":"737_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-023-03080-9","volume":"23","author":"B Hassani","year":"2023","unstructured":"Hassani B, Attar Z, Firouzabadi N.The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell Int. 2023;23(1):254.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"737_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1389450122666210806125919","volume":"23","author":"B Sharma","year":"2022","unstructured":"Sharma B, Hussain T, Khan MA, Jaiswal V.Exploring AT2R and its Polymorphism in Different Diseases: an Approach to Develop AT2R as a Drug Target beyond Hypertension. Curr Drug Targets. 2022;23(1):99\u2013113.","journal-title":"Curr Drug Targets"},{"key":"737_CR38","doi-asserted-by":"crossref","unstructured":"Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the Brain: the Renin Angiotensin System. Int J Mol Sci. 2018;19(3).","DOI":"10.3390\/ijms19030876"},{"issue":"11","key":"737_CR39","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.4103\/1673-5374.336869","volume":"17","author":"E Bajwa","year":"2022","unstructured":"Bajwa E, Klegeris A.Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer\u2019s disease. Neural Regen Res. 2022;17(11):2342\u201346.","journal-title":"Neural Regen Res"},{"key":"737_CR40","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2147\/JIR.S350109","volume":"15","author":"M Wang","year":"2022","unstructured":"Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H. Microglia-Mediated Neuroinflammation: a Potential Target for the Treatment of Cardiovascular Diseases. J Inflamm Res. 2022;15:3083\u201394.","journal-title":"J Inflamm Res"},{"issue":"2","key":"737_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","volume":"29","author":"AJ Miller","year":"2019","unstructured":"Miller AJ, Arnold AC.The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res. 2019;29(2):231\u201343.","journal-title":"Clin Auton Res"},{"issue":"6","key":"737_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11011-021-00728-1","volume":"36","author":"G Mirzahosseini","year":"2021","unstructured":"Mirzahosseini G, Ismael S, Ahmed HA, Ishrat T.Manifestation of renin angiotensin system modulation in traumatic brain injury. Metab Brain Dis. 2021;36(6):1079\u201386.","journal-title":"Metab Brain Dis"},{"key":"737_CR43","doi-asserted-by":"crossref","unstructured":"Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S. Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer\u2019s Disease. Int J Mol Sci. 2021;22(18).","DOI":"10.3390\/ijms221810139"},{"issue":"6","key":"737_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","volume":"86","author":"MI Phillips","year":"2008","unstructured":"Phillips MI, de Oliveira EM.Brain renin angiotensin in disease. J Mol Med (Berl). 2008;86(6):715\u201322.","journal-title":"J Mol Med (Berl)"},{"key":"737_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","volume":"35","author":"MJ McKinley","year":"2003","unstructured":"McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, et al. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003;35:901\u201318.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"737_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","volume":"465","author":"JW Wright","year":"2013","unstructured":"Wright JW, Harding JW.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch. 2013;465(1):133\u201351.","journal-title":"Pflugers Arch"},{"issue":"3","key":"737_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","volume":"27","author":"OA Abiodun","year":"2020","unstructured":"Abiodun OA, Ola MS.Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci. 2020;27(3):905\u201312.","journal-title":"Saudi J Biol Sci"},{"key":"737_CR48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/npp.2010.225","volume":"36","author":"J Benicky","year":"2011","unstructured":"Benicky J, S\u00e1nchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, et al. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 2011;36:857\u201370.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"737_CR49","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1097\/01.hjh.0000220418.09021.ee","volume":"24","author":"JM Saavedra","year":"2006","unstructured":"Saavedra JM, Benicky J, Zhou J.Angiotensin II: multitasking in the brain. J Hypertens Suppl. 2006;24(1):S131\u20137.","journal-title":"J Hypertens Suppl"},{"key":"737_CR50","first-page":"256","volume-title":"Angiotensin Type 2 Receptors: role in Aging and Neuroinflammation in the Substantia Nigra","author":"AI Rodriguez-Perez","year":"2020","unstructured":"Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Valenzuela R, Navarro G, et al. Angiotensin Type 2 Receptors: role in Aging and Neuroinflammation in the Substantia Nigra. vol. 87, Brain Behav Immun; 2020. 256\u201371."},{"key":"737_CR51","doi-asserted-by":"crossref","unstructured":"Gold PW. The PPARg System in Major Depression: pathophysiologic and Therapeutic Implications. Int J Mol Sci. 2021;22(17).","DOI":"10.3390\/ijms22179248"},{"key":"737_CR52","doi-asserted-by":"publisher","first-page":"113674","DOI":"10.1016\/j.bcp.2019.113674","volume":"171","author":"ZF Wang","year":"2020","unstructured":"Wang ZF, Li J, Ma C, Huang C, Li ZQ. Telmisartan ameliorates A\u03b2 oligomer-induced inflammation via PPAR\u03b3\/PTEN pathway in BV2 microglial cells. Biochem Pharmacol. 2020;171:113674.","journal-title":"Biochem Pharmacol"},{"key":"737_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/ars.2017.7003","volume":"28","author":"Y Wang","year":"2018","unstructured":"Wang Y, Huang Y, Xu Y, Ruan W, Wang H, Zhang Y, et al. A Dual AMPK\/Nrf2 Activator Reduces Brain Inflammation After Stroke by Enhancing Microglia M2 Polarization. Antioxid Redox Signal 2018;28:141\u201363.","journal-title":"Antioxid Redox Signal"},{"key":"737_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.31083\/j.jin2302029","volume":"23","author":"B Ray","year":"2024","unstructured":"Ray B, Tuladhar S, Nagaraju PG, Shivalinga A, Mahalakshmi AM, Priyadarshini P, et al. Telmisartan Protects Mitochondrial Function, Gait, and Neuronal Apoptosis by Activating the Akt\/GSK3\u03b2\/PGC1\u03b1 Pathway in an MPTP-Induced Mouse Model of Parkinson\u2019s Disease. J Integr Neurosci 2024;23:29.","journal-title":"J Integr Neurosci"},{"key":"737_CR55","doi-asserted-by":"crossref","unstructured":"Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. Int J Mol Sci. 2021;22(13).","DOI":"10.3390\/ijms22136702"},{"key":"737_CR56","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall JE, Mouton AJ, da Silva AA, Omoto ACM, Wang Z, Li X, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res 2021;117:1859\u201376.","journal-title":"Cardiovasc Res"},{"key":"737_CR57","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","volume":"44","author":"A Ioannou","year":"2023","unstructured":"Ioannou A, Massa P, Patel RK, Razvi Y, Porcari A, Rauf MU, et al. Conventional heart failure therapy in cardiac ATTR amyloidosis. Eur Heart J 2023;44:2893\u2013907.","journal-title":"Eur Heart J"},{"key":"737_CR58","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1681\/ASN.0000000000000248","volume":"34","author":"RA Fletcher","year":"2023","unstructured":"Fletcher RA, Jongs N, Chertow GM, McMurray JJV, Arnott C, Jardine MJ, et al. Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: a Joint Analysis of the CREDENCE and DAPA-CKD Trials. J Am Soc Nephrol 2023;34:1965\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"737_CR59","first-page":"107684","volume-title":"The Role of the Brain Renin-angiotensin System (RAS) in Mild Traumatic Brain Injury (TBI)","author":"JD Vadhan","year":"2021","unstructured":"Vadhan JD, Speth RC. The Role of the Brain Renin-angiotensin System (RAS) in Mild Traumatic Brain Injury (TBI). vol. 218. Pharmacol Ther; 2021. p. 107684."},{"issue":"7-8","key":"737_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/neu.2021.0401","volume":"39","author":"DH Baron","year":"2022","unstructured":"Baron DH, Skrobot OA, Palmer JC, Sharma K, Kehoe PG.Renin Angiotensin System as a Potential Treatment Target for Traumatic Brain Injury: a Systematic Review and Meta-Analysis. J Neurotrauma. 2022;39(7-8):473\u201386.","journal-title":"J Neurotrauma"},{"key":"737_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2016.02.026","volume":"363","author":"M \u017divkovi\u0107","year":"2016","unstructured":"\u017divkovi\u0107 M, Kolakovi\u0107 A, Stojkovi\u0107 L, Din\u010di\u0107 E, Kosti\u0107 S, Alavanti\u0107 D, et al. Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis. J Neurol Sci. 2016;363:29\u201332.","journal-title":"J Neurol Sci"},{"key":"737_CR62","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","volume":"79","author":"Z Deng","year":"2022","unstructured":"Deng Z, Jiang J, Wang J, Pan D, Zhu Y, Li H, et al. Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia. Hypertension 2022;79:2159\u201369.","journal-title":"Hypertension"},{"key":"737_CR63","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, Bicker J, Falc\u00e3o A, Cruz MT, et al. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: past, present and future. Ageing Res Rev. 2022;77:101612.","journal-title":"Ageing Res Rev"},{"key":"737_CR64","doi-asserted-by":"crossref","unstructured":"Sunanda T, Ray B, Mahalakshmi AM, Bhat A, Rashan L, Rungratanawanich W, et al. Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson\u2019s Disease: the Role of Brain Renin Angiotensin System Components. Biomolecules. 2021;11(11).","DOI":"10.3390\/biom11111669"},{"key":"737_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12012-022-09730-0","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu H, Sun Q, Yuan S, Wang J, Li F, Gao H, et al. AT1 Receptors: their Actions from Hypertension to Cognitive Impairment. Cardiovasc Toxicol 2022;22:311\u201325.","journal-title":"Cardiovasc Toxicol"},{"issue":"6","key":"737_CR66","first-page":"463","volume":"27","author":"LM Kangussu","year":"2020","unstructured":"Kangussu LM, Marzano LAS, Souza CF, Dantas CC, Miranda AS, Sim\u00f5es ESAC.The Renin-Angiotensin System and the Cerebrovascular Diseases: experimental and Clinical Evidence. Protein Pept Lett. 2020;27(6):463\u201375.","journal-title":"Protein Pept Lett"},{"key":"737_CR67","doi-asserted-by":"crossref","unstructured":"Andone S, Bajko Z, Motataianu A, Maier S, Barcutean L, Balasa R. Neuroprotection in Stroke-Focus on the Renin-Angiotensin System: a Systematic Review. Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073876"},{"issue":"5","key":"737_CR68","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10571-019-00778-1","volume":"40","author":"RU Parekh","year":"2020","unstructured":"Parekh RU, Robidoux J, Sriramula S.Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons. Cell Mol Neurobiol. 2020;40(5):845\u201357.","journal-title":"Cell Mol Neurobiol"},{"key":"737_CR69","doi-asserted-by":"publisher","first-page":"566410","DOI":"10.3389\/fphys.2020.566410","volume":"11","author":"J Ding","year":"2020","unstructured":"Ding J, Yu M, Jiang J, Luo Y, Zhang Q, Wang S, et al. Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT(1)R Nox\/ROS\/PP2A Pathway. Front Physiol. 2020;11:566410.","journal-title":"Front Physiol"},{"key":"737_CR70","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00424-024-02981-6","volume":"476","author":"J Wei","year":"2024","unstructured":"Wei J, Ai Q, Lv P, Fang W, Wang Z, Zhao J, et al. Acupoint catgut embedding attenuates oxidative stress and cognitive impairment in chronic cerebral ischemia by inhibiting the Ang II\/AT1R\/NOX axis. Pflugers Arch 2024;476:1249\u201361.","journal-title":"Pflugers Arch"},{"key":"737_CR71","first-page":"143","volume-title":"Spinal AT1R Contributes to Neuroinflammation and Neuropathic Pain via NOX2-dependent Redox Signaling in Microglia","author":"W Zhang","year":"2024","unstructured":"Zhang W, Jiao B, Yu S, Zhang K, Sun J, Liu B, et al. Spinal AT1R Contributes to Neuroinflammation and Neuropathic Pain via NOX2-dependent Redox Signaling in Microglia. vol. 227, Free Radic Biol Med; 2024. 143\u201356."},{"key":"737_CR72","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.phrs.2019.04.029","volume":"144","author":"FE Mowry","year":"2019","unstructured":"Mowry FE, Biancardi VC. Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways. Pharmacol Res. 2019;144:279\u201391.","journal-title":"Pharmacol Res"},{"issue":"7","key":"737_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11906-020-01062-0","volume":"22","author":"K Elsaafien","year":"2020","unstructured":"Elsaafien K, de Kloet AD, Krause EG, Sumners C.Brain Angiotensin Type-1 and Type-2 Receptors in Physiological and Hypertensive Conditions: focus on Neuroinflammation. Curr Hypertens Rep. 2020;22(7):48.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"737_CR74","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.1007\/s12035-015-9584-5","volume":"53","author":"SA Bhat","year":"2016","unstructured":"Bhat SA, Goel R, Shukla R, Hanif K.Angiotensin Receptor Blockade Modulates NF\u03baB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition. Mol Neurobiol. 2016;53(10):6950\u201367.","journal-title":"Mol Neurobiol"},{"key":"737_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/neu.2021.0382","volume":"39","author":"T Li","year":"2022","unstructured":"Li T, Huang HY, Wang HD, Gao CC, Liang H, Deng CL, et al. Restoration of Brain Angiotensin-Converting Enzyme 2 Alleviates Neurological Deficits after Severe Traumatic Brain Injury via Mitigation of Pyroptosis and Apoptosis. J Neurotrauma 2022;39:423\u201334.","journal-title":"J Neurotrauma"},{"key":"737_CR76","doi-asserted-by":"crossref","unstructured":"Quijano A, Diaz-Ruiz C, Lopez-Lopez A, Villar-Cheda B, Mu\u00f1oz A, Rodriguez-Perez AI, et al. Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures. Antioxidants (Basel). 2022;11(2).","DOI":"10.3390\/antiox11020329"},{"key":"737_CR77","first-page":"112336","volume-title":"Irbesartan Mitigates the Impact of Cyclophosphamide-induced Acute Neurotoxicity in Rats: shedding Highlights on NLRP3 inflammasome\/CASP-1 Pathway-driven Immunomodulation","author":"RH Abu-Baih","year":"2024","unstructured":"Abu-Baih RH, Ibrahim MFG, Elhamadany EY, Abu-Baih DH. Irbesartan Mitigates the Impact of Cyclophosphamide-induced Acute Neurotoxicity in Rats: shedding Highlights on NLRP3 inflammasome\/CASP-1 Pathway-driven Immunomodulation. vol. 135. Int Immunopharmacol; 2024. p. 112336."},{"issue":"1","key":"737_CR78","doi-asserted-by":"publisher","first-page":"H397","DOI":"10.1152\/ajpheart.00679.2010","volume":"300","author":"C Capone","year":"2011","unstructured":"Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C.The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol. 2011;300(1):H397\u2013407.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"17","key":"737_CR79","doi-asserted-by":"publisher","first-page":"e020608","DOI":"10.1161\/JAHA.120.020608","volume":"10","author":"M Boily","year":"2021","unstructured":"Boily M, Li L, Vallerand D, Girouard H.Angiotensin II Disrupts Neurovascular Coupling by Potentiating Calcium Increases in Astrocytic Endfeet. J Am Heart Assoc. 2021;10(17):e020608.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"737_CR80","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1080\/13880209.2022.2142801","volume":"60","author":"Y Xia","year":"2022","unstructured":"Xia Y, Lu YW, Hao RJ, Yu GR.Catalpol relieved angiotensin II-induced blood-brain barrier destruction via inhibiting the TLR4 pathway in brain endothelial cells. Pharm Biol. 2022;60(1):2210\u201318.","journal-title":"Pharm Biol"},{"key":"737_CR81","first-page":"126","volume-title":"Angiotensin II Type 1 Receptor Blocker Losartan Prevents and Rescues Cerebrovascular, Neuropathological and Cognitive Deficits in an Alzheimer\u2019s Disease Model","author":"B Ongali","year":"2014","unstructured":"Ongali B, Nicolakakis N, Tong XK, Aboulkassim T, Papadopoulos P, Rosa-Neto P, et al. Angiotensin II Type 1 Receptor Blocker Losartan Prevents and Rescues Cerebrovascular, Neuropathological and Cognitive Deficits in an Alzheimer\u2019s Disease Model. vol. 68, Neurobiol Dis; 2014. 126\u201336."},{"key":"737_CR82","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1248\/bpb.b12-00387","volume":"35","author":"T Shindo","year":"2012","unstructured":"Shindo T, Takasaki K, Uchida K, Onimura R, Kubota K, Uchida N, et al. Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer\u2019s disease incorporating additional cerebrovascular disease factors. Biol Pharm Bull 2012;35:2141\u201347.","journal-title":"Biol Pharm Bull"},{"issue":"Pt 11","key":"737_CR83","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/brain\/awv172","volume":"138","author":"S Villapol","year":"2015","unstructured":"Villapol S, Balarezo MG, Affram K, Saavedra JM, Symes AJ.Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain. 2015;138(Pt 11):3299\u2013315.","journal-title":"Brain"},{"issue":"13","key":"737_CR84","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/npp.2012.152","volume":"37","author":"S Villapol","year":"2012","unstructured":"Villapol S, Yaszemski AK, Logan TT, S\u00e1nchez-Lemus E, Saavedra JM, Symes AJ.Candesartan, an angiotensin II AT\u2081-receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacology. 2012;37(13):2817\u201329.","journal-title":"Neuropsychopharmacology"},{"key":"737_CR85","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/rej.2009.0944","volume":"13","author":"L Danielyan","year":"2010","unstructured":"Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, et al. Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 2010;13:195\u2013201.","journal-title":"Rejuvenation Res"},{"key":"737_CR86","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","volume":"54","author":"K Tsukuda","year":"2009","unstructured":"Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, et al. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 2009;54:782\u201387.","journal-title":"Hypertension"},{"key":"737_CR87","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1172\/JCI31547","volume":"117","author":"J Wang","year":"2007","unstructured":"Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 2007;117:3393\u2013402.","journal-title":"J Clin Invest"},{"key":"737_CR88","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archinternmed.2011.1391","volume":"172","author":"I Hajjar","year":"2012","unstructured":"Hajjar I, Hart M, Chen YL, Mack W, Milberg W, Chui H, et al. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial. Arch Intern Med 2012;172:442\u201344.","journal-title":"Arch Intern Med"},{"key":"737_CR89","first-page":"b5465","volume-title":"Use of Angiotensin Receptor Blockers and Risk of Dementia in a Predominantly Male Population: prospective Cohort Analysis","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of Angiotensin Receptor Blockers and Risk of Dementia in a Predominantly Male Population: prospective Cohort Analysis. vol. 340, Bmj; 2010. b5465."},{"issue":"2","key":"737_CR90","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","volume":"12","author":"K Kume","year":"2012","unstructured":"Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T.Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease. Geriatr Gerontol Int. 2012;12(2):207\u201314.","journal-title":"Geriatr Gerontol Int"},{"key":"737_CR91","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.biopha.2018.03.164","volume":"102","author":"A Justin","year":"2018","unstructured":"Justin A, Divakar S, Ramanathan M. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT(1) and not AT(2) receptor. Biomed Pharmacother. 2018;102:947\u201358.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"737_CR92","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s10753-021-01447-6","volume":"44","author":"AE Abd El Aziz","year":"2021","unstructured":"Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS.Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: roles of NF-\u03baB and Nrf2. Inflammation. 2021;44(4):1629\u201342.","journal-title":"Inflammation"},{"issue":"6","key":"737_CR93","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00004872-200307006-00002","volume":"21","author":"T Unger","year":"2003","unstructured":"Unger T.Blood pressure lowering and renin-angiotensin system blockade. J Hypertens Suppl. 2003;21(6):S3\u20137.","journal-title":"J Hypertens Suppl"},{"issue":"3","key":"737_CR94","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/fcp.12872","volume":"37","author":"B Kuber","year":"2023","unstructured":"Kuber B, Fadnavis M, Chatterjee B.Role of angiotensin receptor blockers in the context of Alzheimer\u2019s disease. Fundam Clin Pharmacol. 2023;37(3):429\u201345.","journal-title":"Fundam Clin Pharmacol"},{"key":"737_CR95","first-page":"262","volume-title":"Front Biosci","author":"B Ray","year":"2021","unstructured":"Ray B, Ramesh G, Verma SR, Ramamurthy S, Tuladhar S, Mahalakshmi AM, et al., Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism. Front Biosci (Landmark Ed), 2021. 26(8): p. 262\u201371.","edition":"Landmark"},{"key":"737_CR96","doi-asserted-by":"publisher","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","volume":"12","author":"M Hernandez-Quiles","year":"2021","unstructured":"Hernandez-Quiles M, Broekema MF, Kalkhoven E. PPARgamma in Metabolism, Immunity, and Cancer: unified and Diverse Mechanisms of Action. Front Endocrinol (Lausanne). 2021;12:624112.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"737_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11882-021-01022-x","volume":"21","author":"JM Stark","year":"2021","unstructured":"Stark JM, Coquet JM, Tibbitt CA.The Role of PPAR-\u03b3 in Allergic Disease. Curr Allergy Asthma Rep. 2021;21(11):45.","journal-title":"Curr Allergy Asthma Rep"},{"key":"737_CR98","doi-asserted-by":"publisher","first-page":"115433","DOI":"10.1016\/j.bcp.2023.115433","volume":"209","author":"B Seminotti","year":"2023","unstructured":"Seminotti B, Grings M, Gl\u00e4nzel NM, Vockley J, Leipnitz G. Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders. Biochem Pharmacol. 2023;209:115433.","journal-title":"Biochem Pharmacol"},{"key":"737_CR99","first-page":"154338","volume-title":"The Role of Peroxisome Proliferator-activated Receptors (PPAR) in Immune Responses","author":"A Christofides","year":"2021","unstructured":"Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The Role of Peroxisome Proliferator-activated Receptors (PPAR) in Immune Responses. vol. 114. Metabolism; 2021. p. 154338."},{"issue":"1","key":"737_CR100","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","volume":"38","author":"S Villapol","year":"2018","unstructured":"Villapol S.Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation. Cell Mol Neurobiol. 2018;38(1):121\u201332.","journal-title":"Cell Mol Neurobiol"},{"key":"737_CR101","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-023-02762-5","volume":"20","author":"D He","year":"2023","unstructured":"He D, Fu S, Ye B, Wang H, He Y, Li Z, et al. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models. J Neuroinflammation 2023;20:86.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"737_CR102","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1111\/cns.14333","volume":"29","author":"CH Hsu","year":"2023","unstructured":"Hsu CH, Pan YJ, Zheng YT, Lo RY, Yang FY.Ultrasound reduces inflammation by modulating M1\/M2 polarization of microglia through STAT1\/STAT6\/PPAR\u03b3 signaling pathways. CNS Neurosci Ther. 2023;29(12):4113\u201323.","journal-title":"CNS Neurosci Ther"},{"key":"737_CR103","doi-asserted-by":"publisher","first-page":"e12774","DOI":"10.1111\/acel.12774","volume":"17","author":"J Ji","year":"2018","unstructured":"Ji J, Xue TF, Guo XD, Yang J, Guo RB, Wang J, et al. Antagonizing peroxisome proliferator-activated receptor \u03b3 facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway. Aging Cell 2018;17:e12774.","journal-title":"Aging Cell"},{"key":"737_CR104","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/00207454.2019.1632843","volume":"129","author":"Y Baghcheghi","year":"2019","unstructured":"Baghcheghi Y, Salmani H, Beheshti F, Shafei MN, Sadeghnia HR, Soukhtanloo M, et al. Effects of PPAR-\u03b3 agonist, pioglitazone on brain tissues oxidative damage and learning and memory impairment in juvenile hypothyroid rats. Int J Neurosci 2019;129:1024\u201338.","journal-title":"Int J Neurosci"},{"key":"737_CR105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.gendis.2019.05.002","volume":"7","author":"Y Deng","year":"2020","unstructured":"Deng Y, Jiang X, Deng X, Chen H, Xu J, Zhang Z, et al. Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPAR\u03b3\/NF-\u03baB\/IL-6 signaling pathway. Genes Dis 2020;7:253\u201365.","journal-title":"Genes Dis"},{"key":"737_CR106","first-page":"2010675","volume-title":"Signaling Mechanisms of Selective PPAR\u03b3 Modulators in Alzheimer\u2019s Disease","author":"M Govindarajulu","year":"2018","unstructured":"Govindarajulu M, Pinky PD, Bloemer J, Ghanei N, Suppiramaniam V, Amin R. Signaling Mechanisms of Selective PPAR\u03b3 Modulators in Alzheimer\u2019s Disease. vol. 2018. PPAR Res; 2018. p. 2010675."},{"key":"737_CR107","first-page":"174480691988449","volume-title":"Sustained Relief of Trigeminal Neuropathic Pain by a Blood-brain Barrier Penetrable PPAR Gamma Agonist","author":"M Zhang","year":"2019","unstructured":"Zhang M, Hu M, Montera MA, Westlund KN. Sustained Relief of Trigeminal Neuropathic Pain by a Blood-brain Barrier Penetrable PPAR Gamma Agonist. vol. 15. Mol Pain; 2019. p. 1744806919884498."},{"issue":"7","key":"737_CR108","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1007\/s12035-022-02856-w","volume":"59","author":"RM Mansour","year":"2022","unstructured":"Mansour RM, El Sayed NS, Ahmed MAE, El-Sahar AE.Addressing Peroxisome Proliferator-Activated Receptor-gamma in 3-Nitropropionic Acid-Induced Striatal Neurotoxicity in Rats. Mol Neurobiol. 2022;59(7):4368\u201383.","journal-title":"Mol Neurobiol"},{"key":"737_CR109","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","volume":"43","author":"SC Benson","year":"2004","unstructured":"Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43:993\u20131002.","journal-title":"Hypertension"},{"issue":"4","key":"737_CR110","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/ATVBAHA.112.301125","volume":"33","author":"CD Sigmund","year":"2013","unstructured":"Sigmund CD.A clinical link between peroxisome proliferator-activated receptor \u03b3 and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2013;33(4):676\u201378.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"737_CR111","doi-asserted-by":"publisher","first-page":"e0148921","DOI":"10.1128\/AAC.01489-21","volume":"66","author":"S De","year":"2022","unstructured":"De S, Mamidi P, Ghosh S, Keshry SS, Mahish C, Pani SS, et al. Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1\/PPAR-\u03b3\/MAPKs Pathways. Antimicrob Agents Chemother 2022;66:e0148921.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"737_CR112","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ.Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173(4):649\u201365.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"737_CR113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5853\/jos.2019.02236","volume":"22","author":"C Tschoe","year":"2020","unstructured":"Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ.Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets. J Stroke. 2020;22(1):29\u201346.","journal-title":"J Stroke"},{"key":"737_CR114","doi-asserted-by":"publisher","first-page":"102160","DOI":"10.1016\/j.arr.2023.102160","volume":"93","author":"Y Long","year":"2024","unstructured":"Long Y, Li XQ, Deng J, Ye QB, Li D, Ma Y, et al. Modulating the polarization phenotype of microglia - A valuable strategy for central nervous system diseases. Ageing Res Rev. 2024;93:102160.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"737_CR115","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH.Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"737_CR116","doi-asserted-by":"publisher","first-page":"e0155823","DOI":"10.1371\/journal.pone.0155823","volume":"11","author":"N Torika","year":"2016","unstructured":"Torika N, Asraf K, Danon A, Apte RN, Fleisher-Berkovich S.Telmisartan Modulates Glial Activation. Vitro and in Vivo Studies PLoS One. 2016;11(5):e0155823.","journal-title":"Vitro and in Vivo Studies PLoS One"},{"key":"737_CR117","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-019-1515-3","volume":"16","author":"E Medrano-Jim\u00e9nez","year":"2019","unstructured":"Medrano-Jim\u00e9nez E, Jim\u00e9nez-Ferrer Carrillo I, Pedraza-Escalona M, Ram\u00edrez-Serrano CE, \u00c1lvarez-Arellano L, Cort\u00e9s-Mendoza J, et al. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer\u2019s disease by restoring microglial function via a PPAR-\u03b3-dependent mechanism. J Neuroinflammation 2019;16:143.","journal-title":"J Neuroinflammation"},{"key":"737_CR118","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12974-020-01921-2","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang D, Liu F, Zhu L, Lin P, Han F, Wang X, et al. FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia\/macrophages. J Neuroinflammation 2020;17:257.","journal-title":"J Neuroinflammation"},{"key":"737_CR119","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12974-022-02478-y","volume":"19","author":"X Jiang","year":"2022","unstructured":"Jiang X, Yi S, Liu Q, Su D, Li L, Xiao C, et al. Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-\u03b3 pathway. J Neuroinflammation 2022;19:115.","journal-title":"J Neuroinflammation"},{"key":"737_CR120","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-2094-9-38","volume":"9","author":"P Garrido-Gil","year":"2012","unstructured":"Garrido-Gil P, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson\u2019s disease. J Neuroinflammation. 2012;9:38.","journal-title":"J Neuroinflammation"},{"key":"737_CR121","first-page":"298","volume-title":"Telmisartan Prevention of LPS-induced Microglia Activation Involves M2 Microglia Polarization via CaMKK\u03b2-dependent AMPK Activation","author":"Y Xu","year":"2015","unstructured":"Xu Y, Xu Y, Wang Y, Wang Y, He L, Jiang Z, et al. Telmisartan Prevention of LPS-induced Microglia Activation Involves M2 Microglia Polarization via CaMKK\u03b2-dependent AMPK Activation. vol. 50, Brain Behav Immun; 2015. 298\u2013313."},{"key":"737_CR122","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2009.08.043","volume":"464","author":"T Haraguchi","year":"2009","unstructured":"Haraguchi T, Takasaki K, Naito T, Hayakawa K, Katsurabayashi S, Mishima K, et al. Cerebroprotective action of telmisartan by inhibition of macrophages\/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Neurosci Lett 2009;464:151\u201355.","journal-title":"Neurosci Lett"},{"key":"737_CR123","first-page":"6344","volume-title":"An Environment-dependent Transcriptional Network Specifies Human Microglia Identity","author":"D Gosselin","year":"2017","unstructured":"Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, et al. An Environment-dependent Transcriptional Network Specifies Human Microglia Identity. vol. 356, Science; 2017. 6344."},{"key":"737_CR124","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 2014;34:11929\u201347.","journal-title":"J Neurosci"},{"key":"737_CR125","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1002\/glia.24255","volume":"70","author":"P Garrido-Gil","year":"2022","unstructured":"Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Peque\u00f1o-Valtierra A, Rodr\u00edguez-Castro J, Garc\u00eda-Souto D, et al. Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen. Glia 2022;70:2348\u201360.","journal-title":"Glia"},{"issue":"6","key":"737_CR126","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00429-016-1357-z","volume":"222","author":"P Garrido-Gil","year":"2017","unstructured":"Garrido-Gil P, Rodriguez-Perez AI, Fernandez-Rodriguez P, Lanciego JL, Labandeira-Garcia JL.Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. Brain Struct Funct. 2017;222(6):2559\u201371.","journal-title":"Brain Struct Funct"},{"key":"737_CR127","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/jpet.107.120097","volume":"322","author":"KH Jung","year":"2007","unstructured":"Jung KH, Chu K, Lee ST, Kim SJ, Song EC, Kim EH, et al. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther 2007;322:1051\u201358.","journal-title":"J Pharmacol Exp Ther"},{"key":"737_CR128","doi-asserted-by":"publisher","first-page":"22082","DOI":"10.1038\/s41598-020-79096-2","volume":"10","author":"HS Park","year":"2020","unstructured":"Park HS, You MJ, Yang B, Jang KB, Yoo J, Choi HJ, et al. Chronically infused angiotensin II induces depressive-like behavior via microglia activation. Sci Rep 2020;10:22082.","journal-title":"Sci Rep"},{"key":"737_CR129","first-page":"102420","volume-title":"Angiotensin II Type 1 Receptor Blockade Attenuates the Neuropathological Changes in the Spinal Cords of Diabetic Rats with Modulation of Nuclear Factor Erythroid 2-related Factor 2\/ Heme Oxygenase 1 System","author":"HRH Elsayed","year":"2024","unstructured":"Elsayed HRH, Ali EMT, Rabei MR, El Nashar EM, Alghamdi MA, Al-Zahrani NS, et al. Angiotensin II Type 1 Receptor Blockade Attenuates the Neuropathological Changes in the Spinal Cords of Diabetic Rats with Modulation of Nuclear Factor Erythroid 2-related Factor 2\/ Heme Oxygenase 1 System. vol. 88, Tissue Cell; 2024. 102420."},{"issue":"3","key":"737_CR130","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","volume":"310","author":"VC Biancardi","year":"2016","unstructured":"Biancardi VC, Stranahan AM, Krause EG, de Kloet AD, Stern JE.Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus. Am J Physiol Heart Circ Physiol. 2016;310(3):H404\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"737_CR131","first-page":"143","volume-title":"Spinal AT1R Contributes to Neuroinflammation and Neuropathic Pain via NOX2-dependent Redox Signaling in Microglia","author":"W Zhang","year":"2025","unstructured":"Zhang W, Jiao B, Yu S, Zhang K, Sun J, Liu B, et al. Spinal AT1R Contributes to Neuroinflammation and Neuropathic Pain via NOX2-dependent Redox Signaling in Microglia. vol. 227, Free Radic Biol Med; 2025. 143\u201356."},{"key":"737_CR132","doi-asserted-by":"crossref","unstructured":"Fleisher-Berkovich S, Battaglia V, Baratta F, Brusa P, Ventura Y, Sharon N, et al. An Emerging Strategy for Neuroinflammation Treatment: combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release. Int J Mol Sci. 2023;24(22).","DOI":"10.3390\/ijms242216254"},{"issue":"5","key":"737_CR133","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1007\/s12035-018-1300-9","volume":"56","author":"AG Elkahloun","year":"2019","unstructured":"Elkahloun AG, Rodriguez Y, Alaiyed S, Wenzel E, Saavedra JM.Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPAR\u03b3 Activation. Mol Neurobiol. 2019;56(5):3193\u2013210.","journal-title":"Mol Neurobiol"},{"key":"737_CR134","doi-asserted-by":"publisher","first-page":"739637","DOI":"10.3389\/fphar.2021.739637","volume":"12","author":"T Liu","year":"2021","unstructured":"Liu T, Cui L, Xue H, Yang X, Liu M, Zhi L, et al. Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPAR\u03b3. Front Pharmacol. 2021;12:739637.","journal-title":"Front Pharmacol"},{"issue":"6","key":"737_CR135","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cns.13123","volume":"25","author":"B Zhou","year":"2019","unstructured":"Zhou B, Zuo YX, Jiang RT.Astrocyte morphology: diversity, plasticity, and role in neurological diseases. CNS Neurosci Ther. 2019;25(6):665\u201373.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"737_CR136","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11064-020-02968-6","volume":"45","author":"TM Planas-Font\u00e1nez","year":"2020","unstructured":"Planas-Font\u00e1nez TM, Dreyfus CF, Saitta KS.Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: roles Played by Metabotropic Glutamate Receptors. Neurochem Res. 2020;45(3):541\u201350.","journal-title":"Neurochem Res"},{"key":"737_CR137","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017;541:481\u201387.","journal-title":"Nature"},{"issue":"5","key":"737_CR138","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4062\/biomolther.2020.119","volume":"28","author":"C Jang","year":"2020","unstructured":"Jang C, Kim J, Kwon Y, Jo SA.Telmisartan Inhibits TNF\u03b1-Induced Leukocyte Adhesion by Blocking ICAM-1 Expression in Astroglial Cells but Not in Endothelial Cells. Biomol Ther (Seoul). 2020;28(5):423\u201330.","journal-title":"Biomol Ther (Seoul)"},{"key":"737_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12868-024-00876-x","volume":"25","author":"DN Olschewski","year":"2024","unstructured":"Olschewski DN, Nazarzadeh N, Lange F, Koenig AM, Kulka C, Abraham JA, et al. The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke. BMC Neurosci 2024;25:29.","journal-title":"BMC Neurosci"},{"key":"737_CR140","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12640-018-9921-3","volume":"34","author":"S Sekar","year":"2018","unstructured":"Sekar S, Mani S, Rajamani B, Manivasagam T, Thenmozhi AJ, Bhat A, et al. Telmisartan Ameliorates Astroglial and Dopaminergic Functions in a Mouse Model of Chronic Parkinsonism. Neurotox Res 2018;34:597\u2013612.","journal-title":"Neurotox Res"},{"key":"737_CR141","first-page":"98","volume-title":"Telmisartan Attenuates MPTP Induced Dopaminergic Degeneration and Motor Dysfunction through Regulation of \u03b1-synuclein and Neurotrophic Factors (BDNF and GDNF) Expression in C57BL\/6J Mice","author":"S Sathiya","year":"2013","unstructured":"Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, et al. Telmisartan Attenuates MPTP Induced Dopaminergic Degeneration and Motor Dysfunction through Regulation of \u03b1-synuclein and Neurotrophic Factors (BDNF and GDNF) Expression in C57BL\/6J Mice. vol. 73, Neuropharmacology; 2013. 98\u2013110."},{"key":"737_CR142","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.037","volume":"24","author":"S Kono","year":"2015","unstructured":"Kono S, Kurata T, Sato K, Omote Y, Hishikawa N, Yamashita T, et al. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:537\u201347.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"737_CR143","doi-asserted-by":"publisher","first-page":"174511","DOI":"10.1016\/j.ejphar.2021.174511","volume":"912","author":"ES Said","year":"2021","unstructured":"Said ES, Elsayed AM, Rashed LA, Nadwa EH, Alsuhaibani NA, Alfuraih BS, et al. Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations. Eur J Pharmacol. 2021;912:174511.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"737_CR144","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1007\/s00018-021-03852-4","volume":"78","author":"F Binam\u00e9","year":"2021","unstructured":"Binam\u00e9 F, Pham-Van LD, Bagnard D.Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination. Cell Mol Life Sci. 2021;78(13):5257\u201373.","journal-title":"Cell Mol Life Sci"},{"key":"737_CR145","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/HYPERTENSIONAHA.123.21012","volume":"80","author":"JP Laporte","year":"2023","unstructured":"Laporte JP, Faulkner ME, Gong Z, Akhonda M, Ferrucci L, Egan JM, et al. Hypertensive Adults Exhibit Lower Myelin Content: a Multicomponent Relaxometry and Diffusion Magnetic Resonance Imaging Study. Hypertension 2023;80:1728\u201338.","journal-title":"Hypertension"},{"issue":"4","key":"737_CR146","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10571-017-0550-9","volume":"38","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Guillevin R, Lecarpentier Y.Interactions Between the Canonical WNT\/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis. Cell Mol Neurobiol. 2018;38(4):783\u201395.","journal-title":"Cell Mol Neurobiol"},{"key":"737_CR147","doi-asserted-by":"publisher","first-page":"e3000330","DOI":"10.1371\/journal.pbio.3000330","volume":"17","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhu W, Xu F, Dai X, Shi L, Cai W, et al. The interleukin-4\/PPAR\u03b3 signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury. PLoS Biol 2019;17:e3000330.","journal-title":"PLoS Biol"},{"key":"737_CR148","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bcp.2018.12.001","volume":"159","author":"VR Askari","year":"2019","unstructured":"Askari VR, Shafiee-Nick R. Promising neuroprotective effects of \u03b2-caryophyllene against LPS-induced oligodendrocyte toxicity: a mechanistic study. Biochem Pharmacol. 2019;159:154\u201371.","journal-title":"Biochem Pharmacol"},{"key":"737_CR149","doi-asserted-by":"crossref","unstructured":"Bernardo A, Malara M, Bertuccini L, De Nuccio C, Visentin S, Minghetti L. The Antihypertensive Drug Telmisartan Protects Oligodendrocytes from Cholesterol Accumulation and Promotes Differentiation by a PPAR-\u03b3-Mediated Mechanism. Int J Mol Sci. 2021;22(17).","DOI":"10.3390\/ijms22179434"},{"key":"737_CR150","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1161\/STROKEAHA.110.583948","volume":"41","author":"K Washida","year":"2010","unstructured":"Washida K, Ihara M, Nishio K, Fujita Y, Maki T, Yamada M, et al. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. Stroke 2010;41:1798\u2013806.","journal-title":"Stroke"},{"key":"737_CR151","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.18632\/oncotarget.15774","volume":"8","author":"J Yuan","year":"2017","unstructured":"Yuan J, Ge H, Liu W, Zhu H, Chen Y, Zhang X, et al. M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem\/progenitor cells via the PPAR\u03b3 signaling pathway. Oncotarget 2017;8:19855\u201365.","journal-title":"Oncotarget"},{"key":"737_CR152","doi-asserted-by":"publisher","first-page":"111267","DOI":"10.1016\/j.mad.2020.111267","volume":"189","author":"M Forte","year":"2020","unstructured":"Forte M, Stanzione R, Cotugno M, Bianchi F, Marchitti S, Rubattu S. Vascular ageing in hypertension: focus on mitochondria. Mech Ageing Dev. 2020;189:111267.","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"737_CR153","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP.The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173\u201385.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"737_CR154","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L.A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17(1):69.","journal-title":"Fluids Barriers CNS"},{"key":"737_CR155","first-page":"578060","volume-title":"Inhibition of NOX4\/ROS Suppresses Neuronal and Blood-Brain Barrier Injury by Attenuating Oxidative Stress after Intracerebral Hemorrhage","author":"J Xie","year":"2020","unstructured":"Xie J, Hong E, Ding B, Jiang W, Zheng S, Xie Z, et al. Inhibition of NOX4\/ROS Suppresses Neuronal and Blood-Brain Barrier Injury by Attenuating Oxidative Stress after Intracerebral Hemorrhage. vol. 14, Front Cell Neurosci; 2020. 578060."},{"issue":"8","key":"737_CR156","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han L, Jiang C.Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021;11(8):2306\u201325.","journal-title":"Acta Pharm Sin B"},{"issue":"1_suppl","key":"737_CR157","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1177\/0271678X20951995","volume":"40","author":"PT Ronaldson","year":"2020","unstructured":"Ronaldson PT, Davis TP.Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity. J Cereb Blood Flow Metab. 2020;40(1_suppl):S6\u2013s24.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"737_CR158","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E.Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7(1):41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"737_CR159","first-page":"105278","volume-title":"NMDA Mediates Disruption of Blood-brain Barrier Permeability via Rho\/ROCK Signaling Pathway","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wu Y, Wei J, Huang F, Mao F, Nong W, et al. NMDA Mediates Disruption of Blood-brain Barrier Permeability via Rho\/ROCK Signaling Pathway. vol. 154, Neurochem Int; 2022. 105278."},{"issue":"1","key":"737_CR160","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12640-009-9077-2","volume":"17","author":"HH Wang","year":"2010","unstructured":"Wang HH, Hsieh HL, Wu CY, Yang CM.Oxidized low-density lipoprotein-induced matrix metalloproteinase-9 expression via PKC-delta\/p42\/p44 MAPK\/Elk-1 cascade in brain astrocytes. Neurotox Res. 2010;17(1):50\u201365.","journal-title":"Neurotox Res"},{"key":"737_CR161","doi-asserted-by":"publisher","first-page":"146353","DOI":"10.1016\/j.brainres.2019.146353","volume":"1722","author":"S Guo","year":"2019","unstructured":"Guo S, Som AT, Arai K, Lo EH. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019;1722:146353.","journal-title":"Brain Res"},{"key":"737_CR162","first-page":"782841","volume-title":"Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells","author":"I Khan","year":"2021","unstructured":"Khan I, Schmidt MO, Kallakury B, Jain S, Mehdikhani S, Levi M, et al. Low Dose Chronic Angiotensin II Induces Selective Senescence of Kidney Endothelial Cells. vol. 9, Front Cell Dev Biol; 2021. 782841."},{"issue":"3","key":"737_CR163","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.WCB.0000047369.05600.03","volume":"23","author":"H Yamakawa","year":"2003","unstructured":"Yamakawa H, Jezova M, Ando H, Saavedra JM.Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab. 2003;23(3):371\u201380.","journal-title":"J Cereb Blood Flow Metab"},{"key":"737_CR164","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/jnr.22441","volume":"88","author":"N Oyama","year":"2010","unstructured":"Oyama N, Yagita Y, Sasaki T, Omura-Matsuoka E, Terasaki Y, Sugiyama Y, et al. An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats. J Neurosci Res 2010;88:2889\u201398.","journal-title":"J Neurosci Res"},{"key":"737_CR165","first-page":"107335","volume-title":"Astragaloside IV Promotes Microglia\/macrophages M2 Polarization and Enhances Neurogenesis and Angiogenesis through PPAR\u03b3 Pathway after Cerebral Ischemia\/reperfusion Injury in Rats","author":"L Li","year":"2021","unstructured":"Li L, Gan H, Jin H, Fang Y, Yang Y, Zhang J, et al. Astragaloside IV Promotes Microglia\/macrophages M2 Polarization and Enhances Neurogenesis and Angiogenesis through PPAR\u03b3 Pathway after Cerebral Ischemia\/reperfusion Injury in Rats. vol. 92, Int Immunopharmacol; 2021. 107335."},{"issue":"3","key":"737_CR166","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","volume":"29","author":"MA Fleegal-demotta","year":"2009","unstructured":"Fleegal-demotta MA, Doghu S, Banks WA.Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29(3):640\u201347.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"737_CR167","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/infdis\/jit499","volume":"209","author":"S Krishnan","year":"2014","unstructured":"Krishnan S, Shanmuganathan MV, Behenna D, Stoltz BM, Prasadarao NV.Angiotensin II receptor type 1\u2013a novel target for preventing neonatal meningitis in mice by Escherichia coli K1. J Infect Dis. 2014;209(3):409\u201319.","journal-title":"J Infect Dis"},{"key":"737_CR168","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/01616412.2015.1105626","volume":"38","author":"F Erdi","year":"2016","unstructured":"Erdi F, Keskin F, Esen H, Kaya B, Feyzioglu B, Kilinc I, et al. Telmisartan ameliorates oxidative stress and subarachnoid haemorrhage-induced cerebral vasospasm. Neurol Res 2016;38:224\u201331.","journal-title":"Neurol Res"},{"issue":"1","key":"737_CR169","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1476-5381.2010.00840.x","volume":"161","author":"X Wu","year":"2010","unstructured":"Wu X, Kihara T, Hongo H, Akaike A, Niidome T, Sugimoto H.Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. Br J Pharmacol. 2010;161(1):33\u201350.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"737_CR170","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/aps.2013.199","volume":"35","author":"T Pang","year":"2014","unstructured":"Pang T, Sun LX, Wang T, Jiang ZZ, Liao H, Zhang LY.Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPAR\u03b3 and the Akt\/GSK-3\u03b2 pathway. Acta Pharmacol Sin. 2014;35(6):727\u201337.","journal-title":"Acta Pharmacol Sin"},{"key":"737_CR171","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/HJH.0b013e32833a551a","volume":"28","author":"J Iwanami","year":"2010","unstructured":"Iwanami J, Mogi M, Tsukuda K, Min LJ, Sakata A, Jing F, et al. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice. J Hypertens 2010;28:1730\u201337.","journal-title":"J Hypertens"},{"key":"737_CR172","doi-asserted-by":"publisher","first-page":"e23646","DOI":"10.1371\/journal.pone.0023646","volume":"6","author":"C Thoene-Reineke","year":"2011","unstructured":"Thoene-Reineke C, Rumsch\u00fcssel K, Schmerbach K, Krikov M, Wengenmayer C, Godes M, et al. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS One 2011;6:e23646.","journal-title":"PLoS One"},{"issue":"7","key":"737_CR173","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1139\/cjpp-2017-0042","volume":"95","author":"WAI Khallaf","year":"2017","unstructured":"Khallaf WAI, Messiha BAS, Abo-Youssef AMH, El-Sayed NS.Protective effects of telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuroinflammation, and amyloidogenesis: possible role of brain-derived neurotrophic factor. Can J Physiol Pharmacol. 2017;95(7):850\u201360.","journal-title":"Can J Physiol Pharmacol"},{"key":"737_CR174","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1742-2094-9-102","volume":"9","author":"T Pang","year":"2012","unstructured":"Pang T, Wang J, Benicky J, S\u00e1nchez-Lemus E, Saavedra JM. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1\u03b2 partly through the JNK\/c-Jun and NADPH oxidase pathways. J Neuroinflammation. 2012;9:102.","journal-title":"J Neuroinflammation"},{"key":"737_CR175","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","volume":"15","author":"AI Rodriguez-Perez","year":"2018","unstructured":"Rodriguez-Perez AI, Sucunza D, Pedrosa MA, Garrido-Gil P, Kulisevsky J, Lanciego JL, et al. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death. Neurotherapeutics 2018;15:1063\u201381.","journal-title":"Neurotherapeutics"},{"key":"737_CR176","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fnins.2020.00902","volume":"14","author":"MC Lai","year":"2020","unstructured":"Lai MC, Wu SN, Huang CW. Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na(+) Currents and Hippocampal Neuronal Excitability. Front Neurosci. 2020;14:902.","journal-title":"Front Neurosci"},{"key":"737_CR177","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/17474930231210448","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim J, Olaiya MT, De Silva DA, Norrving B, Bosch J, De Sousa DA, et al. Global stroke statistics 2023: availability of reperfusion services around the world. Int J Stroke 2024;19:253\u201370.","journal-title":"Int J Stroke"},{"key":"737_CR178","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: a Report From the American Heart Association. Circulation 2023;147:e93\u2013e621.","journal-title":"Circulation"},{"issue":"5","key":"737_CR179","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1097\/01.hjh.0000357906.60778.7f","volume":"27","author":"HC Diener","year":"2009","unstructured":"Diener HC.Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs. J Hypertens Suppl. 2009;27(5):S31\u20136.","journal-title":"J Hypertens Suppl"},{"issue":"9","key":"737_CR180","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1586\/14737175.7.9.1085","volume":"7","author":"HC Diener","year":"2007","unstructured":"Diener HC.The PRoFESS trial: future impact on secondary stroke prevention. Expert Rev Neurother. 2007;7(9):1085\u201391.","journal-title":"Expert Rev Neurother"},{"key":"737_CR181","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547\u201359.","journal-title":"N Engl J Med"},{"key":"737_CR182","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","volume":"148","author":"K Teo","year":"2004","unstructured":"Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, et al. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND) trials. Am Heart J 2004;148:52\u201361.","journal-title":"Am Heart J"},{"key":"737_CR183","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","volume":"372","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008;372:1174\u201383.","journal-title":"Lancet"},{"issue":"12","key":"737_CR184","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2174\/1570159X18666200620230321","volume":"18","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen S, Luo Y, Han Z.Crosstalk between Inflammation and the BBB in Stroke. Curr Neuropharmacol. 2020;18(12):1227\u201336.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"737_CR185","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00401-018-1930-z","volume":"137","author":"KL Lambertsen","year":"2019","unstructured":"Lambertsen KL, Finsen B, Clausen BH.Post-stroke inflammation-target or tool for therapy? Acta Neuropathol. 2019;137(5):693\u2013714.","journal-title":"Acta Neuropathol"},{"key":"737_CR186","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12264-019-00388-3","volume":"35","author":"C Qin","year":"2019","unstructured":"Qin C, Zhou LQ, Ma XT, Hu ZW, Yang S, Chen M, et al. Dual Functions of Microglia in Ischemic Stroke. Neurosci Bull 2019;35:921\u201333.","journal-title":"Neurosci Bull"},{"key":"737_CR187","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1291\/hypres.31.161","volume":"31","author":"M Iwai","year":"2008","unstructured":"Iwai M, Inaba S, Tomono Y, Kanno H, Iwanami J, Mogi M, et al. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice. Hypertens Res 2008;31:161\u201368.","journal-title":"Hypertens Res"},{"issue":"12","key":"737_CR188","doi-asserted-by":"publisher","first-page":"105255","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105255","volume":"29","author":"YY Li","year":"2020","unstructured":"Li YY, Guo JH, Liu YQ, Dong JH, Zhu CH.PPAR\u03b3 Activation-Mediated Egr-1 Inhibition Benefits Against Brain Injury in an Experimental Ischaemic Stroke Model. J Stroke Cerebrovasc Dis. 2020;29(12):105255.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"737_CR189","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cyto.2013.02.001","volume":"62","author":"L Klinghammer","year":"2013","unstructured":"Klinghammer L, Urschel K, Cicha I, Lewczuk P, Raaz-Schrauder D, Achenbach S, et al. Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis\u2013influence on IP-10, TNF-\u03b1 and MCP-1. Cytokine 2013;62:290\u201396.","journal-title":"Cytokine"},{"key":"737_CR190","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1007\/s12035-020-02253-1","volume":"58","author":"HS Kwon","year":"2021","unstructured":"Kwon HS, Ha J, Kim JY, Park HH, Lee EH, Choi H, et al. Telmisartan Inhibits the NLRP3 Inflammasome by Activating the PI3K Pathway in Neural Stem Cells Injured by Oxygen-Glucose Deprivation. Mol Neurobiol 2021;58:1806\u201318.","journal-title":"Mol Neurobiol"},{"key":"737_CR191","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","volume":"132","author":"K Visser","year":"2022","unstructured":"Visser K, Koggel M, Blaauw J, van der Horn HJ, Jacobs B, van der Naalt J. Blood-based biomarkers of inflammation in mild traumatic brain injury: a systematic review. Neurosci Biobehav Rev. 2022;132:154\u201368.","journal-title":"Neurosci Biobehav Rev"},{"issue":"23","key":"737_CR192","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1089\/neu.2021.0062","volume":"38","author":"J Haarbauer-Krupa","year":"2021","unstructured":"Haarbauer-Krupa J, Pugh MJ, Prager EM, Harmon N, Wolfe J, Yaffe K.Epidemiology of Chronic Effects of Traumatic Brain Injury. J Neurotrauma. 2021;38(23):3235\u201347.","journal-title":"J Neurotrauma"},{"key":"737_CR193","doi-asserted-by":"publisher","first-page":"1090672","DOI":"10.3389\/fnins.2023.1090672","volume":"17","author":"SH Rauchman","year":"2023","unstructured":"Rauchman SH, Zubair A, Jacob B, Rauchman D, Pinkhasov A, Placantonakis DG, et al. Traumatic brain injury: mechanisms, manifestations, and visual sequelae. Front Neurosci. 2023;17:1090672.","journal-title":"Front Neurosci"},{"key":"737_CR194","doi-asserted-by":"publisher","first-page":"740939","DOI":"10.3389\/fphys.2021.740939","volume":"12","author":"RG Mira","year":"2021","unstructured":"Mira RG, Lira M, Cerpa W. Traumatic Brain Injury: mechanisms of Glial Response. Front Physiol. 2021;12:740939.","journal-title":"Front Physiol"},{"key":"737_CR195","first-page":"149266","volume-title":"Involvement of Renin-Angiotensin System (RAS) Components in Mild Traumatic Brain Injury","author":"CA Machado","year":"2025","unstructured":"Machado CA, Oliveira BDS, de Barros J, Fernandes HB, de Brito Toscano EC, Kangussu LM, et al. Involvement of Renin-Angiotensin System (RAS) Components in Mild Traumatic Brain Injury. vol. 1846, Brain Res; 2025. 149266."},{"key":"737_CR196","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fendo.2017.00231","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou J, Burns MP, Huynh L, Villapol S, Taub DD, Saavedra JM, et al. Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice. Front Endocrinol (Lausanne). 2017;8:231.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"737_CR197","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","volume":"36","author":"X Wei","year":"2016","unstructured":"Wei X, Hu CC, Zhang YL, Yao SL, Mao WK.Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury. J Huazhong Univ Sci Technolog Med Sci. 2016;36(4):576\u201383.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"737_CR198","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.ajpath.2015.06.016","volume":"185","author":"S Villapol","year":"2015","unstructured":"Villapol S, Kryndushkin D, Balarezo MG, Campbell AM, Saavedra JM, Shewmaker FP, et al. Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan. Am J Pathol 2015;185:2641\u201352.","journal-title":"Am J Pathol"},{"key":"737_CR199","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","volume":"80","author":"RC Petersen","year":"2023","unstructured":"Petersen RC, Weintraub S, Sabbagh M, Karlawish J, Adler CH, Dilworth-Anderson P, et al. A New Framework for Dementia Nomenclature. JAMA Neurol 2023;80:1364\u201370.","journal-title":"JAMA Neurol"},{"key":"737_CR200","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41582-023-00884-1","volume":"19","author":"S Hosoki","year":"2023","unstructured":"Hosoki S, Hansra GK, Jayasena T, Poljak A, Mather KA, Catts VS, et al. Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol 2023;19:737\u201353.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"737_CR201","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/YCO.0000000000000843","volume":"36","author":"SM Loi","year":"2023","unstructured":"Loi SM, Pijnenburg Y, Velakoulis D.Recent research advances in young-onset dementia. Curr Opin Psychiatry. 2023;36(2):126\u201333.","journal-title":"Curr Opin Psychiatry"},{"key":"737_CR202","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, et al. Dementia with Lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement 2023;19:318\u201332.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"737_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH.Neuroinflammation in Alzheimer\u2019s Disease: current Progress in Molecular Signaling and Therapeutics. Inflammation. 2023;46(1):1\u201317.","journal-title":"Inflammation"},{"issue":"2","key":"737_CR204","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/alz.12680","volume":"19","author":"TJ Littlejohns","year":"2023","unstructured":"Littlejohns TJ, Collister JA, Liu X, Clifton L, Tapela NM, Hunter DJ.Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia. Alzheimers Dement. 2023;19(2):467\u201376.","journal-title":"Alzheimers Dement"},{"key":"737_CR205","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"737_CR206","doi-asserted-by":"crossref","unstructured":"Twarowski B, Herbet M. Inflammatory Processes in Alzheimer\u2019s Disease-Pathomechanism, Diagnosis and Treatment: a Review. Int J Mol Sci. 2023;24(7).","DOI":"10.3390\/ijms24076518"},{"issue":"3","key":"737_CR207","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P.Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"737_CR208","doi-asserted-by":"crossref","unstructured":"Rajesh Y, Kanneganti TD. Innate Immune Cell Death in Neuroinflammation and Alzheimer\u2019s Disease. Cells. 2022;11(12).","DOI":"10.3390\/cells11121885"},{"key":"737_CR209","doi-asserted-by":"crossref","unstructured":"Esther Rubavathy SM, Prakash M. Computational insights in repurposing a cardiovascular drug for Alzheimer\u2019s disease: the role of aromatic amino acids in stabilizing the drug through \u03c0-\u03c0 stacking interaction. Phys Chem Chem Phys. 2024.","DOI":"10.1039\/D4CP03291H"},{"key":"737_CR210","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/alz.12819","volume":"19","author":"P Zhang","year":"2023","unstructured":"Zhang P, Hou Y, Tu W, Campbell N, Pieper AA, Leverenz JB, et al. Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer\u2019s disease in African Americans. Alzheimers Dement 2023;19:1876\u201387.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"737_CR211","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12640-019-00085-z","volume":"37","author":"M Khalifa","year":"2020","unstructured":"Khalifa M, Safar MM, Abdelsalam RM, Zaki HF.Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats. Neurotox Res. 2020;37(2):275\u201385.","journal-title":"Neurotox Res"},{"key":"737_CR212","doi-asserted-by":"publisher","first-page":"117388","DOI":"10.1016\/j.lfs.2020.117388","volume":"245","author":"NF Abdelkader","year":"2020","unstructured":"Abdelkader NF, Abd El-Latif AM, Khattab MM. Telmisartan\/17\u03b2-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer\u2019s disease: modulation of ACE1\/ACE2 and AT1\/AT2 ratio. Life Sci. 2020;245:117388.","journal-title":"Life Sci"},{"key":"737_CR213","doi-asserted-by":"publisher","first-page":"111441","DOI":"10.1016\/j.fct.2020.111441","volume":"142","author":"AM Abo-Youssef","year":"2020","unstructured":"Abo-Youssef AM, Khallaf WA, Khattab MM, Messiha BAS. The anti-Alzheimer effect of telmisartan in a hyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors. Food Chem Toxicol. 2020;142:111441.","journal-title":"Food Chem Toxicol"},{"key":"737_CR214","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12975-013-0321-y","volume":"6","author":"T Kurata","year":"2015","unstructured":"Kurata T, Lukic V, Kozuki M, Wada D, Miyazaki K, Morimoto N, et al. Long-term effect of telmisartan on Alzheimer\u2019s amyloid genesis in SHR-SR after tMCAO. Transl Stroke Res 2015;6:107\u201315.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"737_CR215","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","volume":"19","author":"T Rundek","year":"2022","unstructured":"Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ.Vascular Cognitive Impairment (VCI). Neurotherapeutics. 2022;19(1):68\u201388.","journal-title":"Neurotherapeutics"},{"key":"737_CR216","doi-asserted-by":"publisher","first-page":"308","DOI":"10.14336\/AD.2020.0427","volume":"12","author":"H Kuang","year":"2021","unstructured":"Kuang H, Zhou ZF, Zhu YG, Wan ZK, Yang MW, Hong FF, et al. Pharmacological Treatment of Vascular Dementia: a Molecular Mechanism Perspective. Aging Dis 2021;12:308\u201326.","journal-title":"Aging Dis"},{"issue":"1","key":"737_CR217","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13760-021-01664-8","volume":"123","author":"M Daniela","year":"2023","unstructured":"Daniela M, Grigoras C, Cuciureanu D, Constantinescu V.The circadian rhythm of arterial blood pressure in Alzheimer\u2019s disease and vascular dementia. Acta Neurol Belg. 2023;123(1):129\u201337.","journal-title":"Acta Neurol Belg"},{"key":"737_CR218","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.025","volume":"27","author":"Y Gao","year":"2018","unstructured":"Gao Y, Li W, Liu Y, Wang Y, Zhang J, Li M, et al. Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-\u03b3 in Vascular Dementia Spontaneously Hypertensive Rats. J Stroke Cerebrovasc Dis 2018;27:277\u201385.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"737_CR219","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pbb.2012.03.029","volume":"102","author":"B Sharma","year":"2012","unstructured":"Sharma B, Singh N.Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacol Biochem Behav. 2012;102(1):101\u201308.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"737_CR220","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jjcc.2012.08.004","volume":"60","author":"T Kishi","year":"2012","unstructured":"Kishi T, Hirooka Y, Sunagawa K.Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor\/tropomyosin-related kinase B in hippocampus of hypertensive rats. J Cardiol. 2012;60(6):489\u201394.","journal-title":"J Cardiol"},{"key":"737_CR221","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3233\/JAD-161198","volume":"61","author":"W Wharton","year":"2018","unstructured":"Wharton W, Goldstein FC, Tansey MG, Brown AL, Tharwani SD, Verble DD, et al. Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer\u2019s (HEART) Trial. J Alzheimers Dis 2018;61:815\u201324.","journal-title":"J Alzheimers Dis"},{"key":"737_CR222","doi-asserted-by":"publisher","first-page":"e1003707","DOI":"10.1371\/journal.pmed.1003707","volume":"18","author":"CH Liu","year":"2021","unstructured":"Liu CH, Sung PS, Li YR, Huang WK, Lee TW, Huang CC, et al. Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: a population-based cohort study. PLoS Med 2021;18:e1003707.","journal-title":"PLoS Med"},{"key":"737_CR223","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fnagi.2020.00154","volume":"12","author":"W Hu","year":"2020","unstructured":"Hu W, Li Y, Zhao Y, Dong Y, Cui Y, Sun S, et al. Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype. Front Aging Neurosci. 2020;12:154.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"737_CR224","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM.Parkinson\u2019s Disease: a Multisystem Disorder. Neurosci Bull. 2023;39(1):113\u201324.","journal-title":"Neurosci Bull"},{"issue":"1","key":"737_CR225","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P.Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):73.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"737_CR226","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","volume":"44","author":"B Zhu","year":"2022","unstructured":"Zhu B, Yin D, Zhao H, Zhang L.The immunology of Parkinson\u2019s disease. Semin Immunopathol. 2022;44(5):659\u201372.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"737_CR227","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41531-024-00650-0","volume":"10","author":"L Lage","year":"2024","unstructured":"Lage L, Rodriguez-Perez AI, Villar-Cheda B, Labandeira-Garcia JL, Dominguez-Meijide A.Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission. NPJ Parkinsons Dis. 2024;10(1):37.","journal-title":"NPJ Parkinsons Dis"},{"key":"737_CR228","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejphar.2016.02.042","volume":"776","author":"Q Tong","year":"2016","unstructured":"Tong Q, Wu L, Jiang T, Ou Z, Zhang Y, Zhu D. Inhibition of endoplasmic reticulum stress-activated IRE1\u03b1-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson\u2019s disease. Eur J Pharmacol. 2016;776:106\u201315.","journal-title":"Eur J Pharmacol"},{"key":"737_CR229","doi-asserted-by":"crossref","unstructured":"Zhao X, Jacob C. Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis. Int J Mol Sci. 2023;24(7).","DOI":"10.3390\/ijms24076373"},{"issue":"1","key":"737_CR230","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G.Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27\u201340.","journal-title":"Eur J Neurol"},{"key":"737_CR231","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11481-019-09894-7","volume":"15","author":"RE Stone","year":"2020","unstructured":"Stone RE, Liu S, Levy AM, Kashani N, Louie SG, Rodgers KE, et al. Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease. J Neuroimmune Pharmacol 2020;15:249\u201363.","journal-title":"J Neuroimmune Pharmacol"},{"key":"737_CR232","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"S Rodr\u00edguez Mur\u00faa","year":"2022","unstructured":"Rodr\u00edguez Mur\u00faa S, Farez MF, Quintana FJ. The Immune Response in Multiple Sclerosis. Annu Rev Pathol. 2022;17:121\u201339.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"737_CR233","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD.Diagnosis and Treatment of Multiple Sclerosis: a Review. Jama. 2021;325(8):765\u201379.","journal-title":"Jama"},{"key":"737_CR234","doi-asserted-by":"crossref","unstructured":"Fleisher-Berkovich S, Ventura Y, Amoyal M, Dahan A, Feinshtein V, Alfahel L, et al. Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: modulation of Microglial Activation In Vitro and In Vivo. Biomolecules. 2023;13(2).","DOI":"10.3390\/biom13020376"},{"key":"737_CR235","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbb.2016.06.010","volume":"148","author":"D Wincewicz","year":"2016","unstructured":"Wincewicz D, Juchniewicz A, Waszkiewicz N, Braszko JJ. Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression. Pharmacol Biochem Behav. 2016;148:108\u201318.","journal-title":"Pharmacol Biochem Behav"},{"key":"737_CR236","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2015.04.037","volume":"761","author":"A Bali","year":"2015","unstructured":"Bali A, Jaggi AS. Investigations in foot shock stress of variable intensity in mice: adaptation and role of angiotensin II. Eur J Pharmacol. 2015;761:86\u201394.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"737_CR237","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.pharep.2013.11.002","volume":"66","author":"D Wincewicz","year":"2014","unstructured":"Wincewicz D, Braszko JJ.Telmisartan attenuates cognitive impairment caused by chronic stress in rats. Pharmacol Rep. 2014;66(3):436\u201341.","journal-title":"Pharmacol Rep"},{"key":"737_CR238","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12888-018-1880-y","volume":"18","author":"J Li","year":"2018","unstructured":"Li J, Yang R, Xia K, Wang T, Nie B, Gao K, et al. Effects of stress on behavior and resting-state fMRI in rats and evaluation of Telmisartan therapy in a stress-induced depression model. BMC Psychiatry 2018;18:337.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"737_CR239","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharep.2016.12.004","volume":"69","author":"U Aswar","year":"2017","unstructured":"Aswar U, Chepurwar S, Shintre S, Aswar M.Telmisartan attenuates diabetes induced depression in rats. Pharmacol Rep. 2017;69(2):358\u201364.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"737_CR240","doi-asserted-by":"publisher","first-page":"14021","DOI":"10.1038\/s41598-017-14265-4","volume":"7","author":"Y Li","year":"2017","unstructured":"Li Y, Cheng KC, Liu KF, Peng WH, Cheng JT, Niu HS.Telmisartan Activates PPAR\u03b4 to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice. Sci Rep. 2017;7(1):14021.","journal-title":"Sci Rep"},{"issue":"6","key":"737_CR241","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40263-019-00632-4","volume":"33","author":"SJ Oh","year":"2019","unstructured":"Oh SJ, Fan X.The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: implications for Pharmacotherapy. CNS Drugs. 2019;33(6):539\u201347.","journal-title":"CNS Drugs"},{"key":"737_CR242","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/acps.12799","volume":"136","author":"X Fan","year":"2017","unstructured":"Fan X, Song X, Zhao M, Jarskog LF, Natarajan R, Shukair N, et al. The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia. Acta Psychiatr Scand 2017;136:465\u201372.","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"737_CR243","doi-asserted-by":"publisher","first-page":"153010","DOI":"10.1016\/j.prp.2020.153010","volume":"216","author":"M Hashemzehi","year":"2020","unstructured":"Hashemzehi M, Beheshti F, Hassanian SM, Ferns GA, Khazaei M, Avan A.Therapeutic potential of renin angiotensin system inhibitors in cancer cells metastasis. Pathol Res Pract. 2020;216(7):153010.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"737_CR244","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.neo.2020.08.002","volume":"22","author":"A Singh","year":"2020","unstructured":"Singh A, Srivastava N, Yadav A, Ateeq B.Targeting AGTR1\/NF-\u03baB\/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma. Neoplasia. 2020;22(10):497\u2013510.","journal-title":"Neoplasia"},{"key":"737_CR245","doi-asserted-by":"crossref","unstructured":"Tan DC, Roth IM, Wickremesekera AC, Davis PF, Kaye AH, Mantamadiotis T, et al. Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System. Cells. 2019;8(11).","DOI":"10.3390\/cells8111364"},{"key":"737_CR246","doi-asserted-by":"crossref","unstructured":"Panza S, Malivindi R, Caruso A, Russo U, Giordano F, Gy\u0151rffy B, et al. Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II\/AGTR1 Signaling in Glioblastoma Cells. Cancers (Basel). 2021;13(18).","DOI":"10.3390\/cancers13184555"},{"issue":"10","key":"737_CR247","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/CAD.0000000000001509","volume":"34","author":"U Kumar","year":"2023","unstructured":"Kumar U, Aich J, Devarajan S.Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach. Anticancer Drugs. 2023;34(10):1094\u2013103.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"737_CR248","first-page":"5859","volume":"15","author":"S Zhang","year":"2018","unstructured":"Zhang S, Wang Y.Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K\/AKT signaling pathway. Oncol Lett. 2018;15(4):5859\u201364.","journal-title":"Oncol Lett"},{"key":"737_CR249","doi-asserted-by":"crossref","unstructured":"Matsui T, Chiyo T, Kobara H, Fujihara S, Fujita K, Namima D, et al. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo. Int J Mol Sci. 2019;20(13).","DOI":"10.3390\/ijms20133197"},{"issue":"3","key":"737_CR250","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ajco.13574","volume":"18","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang T, Li C, Guo J, Xu B, Xue L.Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation. Asia Pac J Clin Oncol. 2022;18(3):217\u201323.","journal-title":"Asia Pac J Clin Oncol"},{"key":"737_CR251","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12935-023-02963-1","volume":"23","author":"YL Chang","year":"2023","unstructured":"Chang YL, Chou CH, Li YF, Huang LC, Kao Y, Hueng DY, et al. Antiproliferative and apoptotic effects of telmisartan in human glioma cells. Cancer Cell Int 2023;23:111.","journal-title":"Cancer Cell Int"},{"key":"737_CR252","doi-asserted-by":"crossref","unstructured":"Rout S, Satapathy BS, Sahoo RN, Pattnaik S. Telmisartan loaded lipid nanocarrier as a potential repurposing approach to treat glioma: characterization, apoptosis evaluation in U87MG cells, pharmacokinetic and molecular simulation study. Nanotechnology. 2024;35(42).","DOI":"10.1088\/1361-6528\/ad64e0"},{"key":"737_CR253","first-page":"2535","volume-title":"Toward a Noncytotoxic Glioblastoma Therapy: blocking MCP-1 with the MTZ Regimen","author":"ME Salacz","year":"2016","unstructured":"Salacz ME, Kast RE, Saki N, Br\u00fcning A, Karpel-Massler G, Halatsch ME. Toward a Noncytotoxic Glioblastoma Therapy: blocking MCP-1 with the MTZ Regimen. vol. 9. Onco Targets Ther; 2016. p. 2535\u201345."},{"key":"737_CR254","first-page":"112707","volume-title":"Anti-tumor Effects of Telmisartan in Glioma-astrocyte Non-contact Co-cultures: a Critical Role of Astrocytic IL-6-mediated Paracrine Growth Promotion","author":"W Quan","year":"2024","unstructured":"Quan W, Xu CS, Ma C, Chen X, Yu DH, Li ZY, et al. Anti-tumor Effects of Telmisartan in Glioma-astrocyte Non-contact Co-cultures: a Critical Role of Astrocytic IL-6-mediated Paracrine Growth Promotion. vol. 139, Int Immunopharmacol; 2024. 112707."},{"issue":"2","key":"737_CR255","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-017-2528-3","volume":"134","author":"VA Levin","year":"2017","unstructured":"Levin VA, Chan J, Datta M, Yee JL, Jain RK.Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and\/or bevacizumab. J Neurooncol. 2017;134(2):325\u201330.","journal-title":"J Neurooncol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00737-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:17:18Z","timestamp":1758082638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":255,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00737-2","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}